News
At the 2014 annual meeting of the American Society for Radiation Oncology (ASTRO), Sept. 14-17 at San Francisco’s Moscone Center, Siemens Healthcare demonstrated how it innovates to advance the practice of radiation therapy (RT) for the benefit of patients by providing systems and solutions that enable optimal imaging, which can support radiation therapy (RT) treatment and follow-up.
September 17, 2014 
News
IBA and Philips Healthcare announced the signing of a global collaboration to provide advanced diagnostic and therapeutic solutions for the treatment of cancer.
September 17, 2014 
News
Cianna Medical Inc. announced five-year results for the first 200 hundred patients treated with the SAVI breast brachytherapy applicator, including excellent local control, low rates of toxicities and excellent cosmetic results.
September 17, 2014 Sponsored Content
Feature | Breast Imaging
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
December 03, 2024 
Technology
September 16, 2014 — CivaTech Oncology announced it has received U.S. Food and Drug Administration (FDA) clearance on its bioabsorbable planar radiation device. The implantable CivaSheet low-dose-rate (LDR) Palladium source is the only membrane-like brachytherapy device that is truly customizable to a specific patient’s condition and offers a unidirectional option to shield healthy tissue.
September 16, 2014 News
September 16, 2014 — Advanced Accelerator Applications (AAA), an international specialist in molecular nuclear medicine, announced this week it has entered into an agreement with GE Healthcare in Italy to acquire its Italian FDG-PET imaging agent business (fluorodeoxyglucose positron emission tomography). This acquisition includes the license to market GE Healthcare’s SteriPET (FDG) imaging agent in Italy.
September 16, 2014 Sponsored Content
News | Computed Tomography (CT) | August 06, 2024
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
News
September 16, 2014 — A large, international analysis of patients with stage IV non-small cell lung cancer (NSCLC) indicates that a patient’s overall survival (OS) rate can be related to factors including the timing of when metastases develop and lymph node involvement, and that aggressive treatment for “low-risk” patients leads to a five-year OS rate of 47.8 percent. The research was presented today at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO).
September 16, 2014 Sponsored Content
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
September 25, 2024 Feature
Patients with inoperable, early-stage lung cancer who receive stereotactic body radiation therapy (SBRT) have a five-year survival rate of 40 percent, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.
September 16, 2014 Feature
A prospective clinical study that compared patient-reported outcomes of a broad set of cancer patients with bone metastases demonstrates that single fraction radiation therapy (SFRT) is equally as effective as multiple fraction radiation therapy (MFRT) when pain, function and quality of life are considered, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.
September 16, 2014 
Feature
Mobility is equally preserved in cancer patients suffering from malignant spinal cord compression (MSCC) who receive a single dose of 10 Gy of radiation therapy (RT), compared to patients who receive five daily doses of 4 Gy of RT each, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.
September 16, 2014 Sponsored Content
News | Computed Tomography (CT)
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
August 06, 2024 
Feature
Prostate cancer patients who received hypofractionated (HPFX) radiation therapy (RT) reported that their quality of life, as well as bladder and bowel function, were at similar levels before and after RT, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.
September 15, 2014 
News
September 15, 2014 — A comparison of five-year sexual function outcomes, as reported by patients treated with external beam radiation therapy (EBRT) versus combination EBRT plus brachytherapy, indicates the utilization of vessel-sparing radiation therapy makes cure possible without compromising long-term sexual function, according to research presented today at ASTRO 2014.
September 15, 2014 
News
September 15, 2014 — The American Society for Radiation Oncology (ASTRO) released its second list of five radiation oncology-specific treatments that are commonly ordered but may not always be appropriate, as part of the national Choosing Wisely campaign, an initiative of the ABIM Foundation.
September 15, 2014 Sponsored Content
News | Artificial Intelligence
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
June 21, 2024 
News
September 15, 2014 — The American Association of Neurological Surgeons (AANS) and the American Society for Radiation Oncology (ASTRO) announced they are partnering to launch and support a national registry for stereotactic radiosurgery (SRS) treatments.
September 15, 2014 News
September 15, 2014 — A secondary analysis of the National Surgical Adjuvant Breast and Bowel Project B-32 trial (Krag 2010) indicates that radiation therapy does not increase the incidence of lymphedema in patients with node-negative breast cancer, according to research presented this week at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO).
September 15, 2014 Sponsored Content
News | Artificial Intelligence | June 21, 2024
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
News
Shorter Course of Androgen Deprivation Therapy Improved Quality of Life for Prostate Cancer Patients
High-risk prostate cancer patients who receive radiation therapy and an 18-month course of androgen deprivation therapy recover a normal testosterone level in a shorter amount of time compared to those who receive a 36-month course of ADT, thus resulting in a better quality of life and without detriment to long-term outcomes, according to research presented at ASTRO 2014.
September 15, 2014 
Feature
Patient-reported data indicates that when Manuka honey is prescribed for esophagitis pain during radiation therapy (RT), it is not more effective than standard medical care, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.
September 15, 2014 
Feature
Patients with stage I and II Hodgkin’s Disease who receive consolidated radiation therapy (RT) have a higher 10-year survival rate of 84 percent, compared to 76 percent for patients who did not receive RT; and, the data also shows a decrease in utilization of RT, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.
September 15, 2014 
Feature
Radiation therapy (RT) alone is as effective in decreasing swallowing complications experienced by advanced esophageal cancer patients as RT combined with chemotherapy, thus allowing patients to forgo chemotherapy, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.
September 15, 2014 
News
September 12, 2014 — Civco Medical Solutions will be featuring an expansive solution lineup at the upcoming annual meeting of the American Society for Radiation Oncology (ASTRO) in San Francisco, including more advanced patient positioning options for stereotactic body radiation therapy (SBRT) and SRS/SRT (stereotactic radiosurgery/stereotactic radiotherapy) treatments.
September 12, 2014 
News
September 12, 2014 — Mevion Medical Systems introduced Hyperscan for the Mevion S250 modular single-room proton therapy system. Benefiting from direct and efficient proton beam generation, Hyperscan’s patented technology allows radiation to be precisely delivered using a sharp beam of radiation, with the tumor being volumetrically scanned in a matter of seconds.
September 12, 2014 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now